Imunon (IMNN) Net Equity Issued and Repurchased (2010 - 2025)

Imunon (IMNN) has 15 years of Net Equity Issued and Repurchased data on file, last reported at $7.2 million in Q4 2025.

• Quarterly Net Equity Issued and Repurchased rose 219532.99% year-over-year to $7.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $13.6 million (up 4385.91% YoY) and the FY2025 annual result came in at $13.6 million, up 50.41% from the prior year.
• Net Equity Issued and Repurchased rose to $7.2 million in Q4 2025, from $3.5 million in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $38.9 million in Q1 2021 to a low of -$21.8 million in Q4 2022.
• A 5-year average of $7.1 million and a median of $198562.0 in 2023 frame the typical range for Net Equity Issued and Repurchased.
• The widest YoY moves for Net Equity Issued and Repurchased: up 266453.74% in 2022, down 2177734700.0% in 2022.
• Tracing IMNN's Net Equity Issued and Repurchased over 5 years: stood at $1.0 in 2021, then slumped by 2177734700.0% to -$21.8 million in 2022, then jumped by 100.14% to $30248.0 in 2023, then slumped by 110.83% to -$3277.0 in 2024, then surged by 219532.99% to $7.2 million in 2025.
• The last three Net Equity Issued and Repurchased figures came in at $7.2 million (Q4 2025), $3.5 million (Q3 2025), and $2.9 million (Q2 2025), per Business Quant data.